The company has improved its financial position, reducing the debt-to-equity ratio to 0.76 in 2026Q1 from a peak of 0.94 in 2025Q4.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 |
|---|
| Total Current Assets | 44.99B | 35.99B | 38B | 40.76B | 30.13B | 28.5B | 23.39B | 20.32B | 12B | 8.7B | 8.37B | 3.6B | 3.03B | 1.8B | 1.37B | 940.01M | 656.82M | 616.13M | 666.34M | 446.34M | 451.82M | 272.61M | 224.29M | 110.3M | 93.09M | 102.05M | 46.72M |
| Cash & Short-Term Investments | 23.74B | 17.89B | 16.68B | 19.65B | 14.39B | 14.66B | 12.38B | 12.99B | 6.06B | 4.6B | 4.43B | 1.94B | 1.79B | 1.14B | 983.07M | 704.2M | 455.51M | 443.31M | 488.49M | 314.85M | 337.97M | 204.06M | 178.39M | 79.51M | 69.23M | 90.04M | 26.42M |
| Cash Only | 21.26B | 17.89B | 14.06B | 17.19B | 12.07B | 13.12B | 10.8B | 12.12B | 5.34B | 4.07B | 3.93B | 1.76B | 1.61B | 1.04B | 843.95M | 573.7M | 434.17M | 403.75M | 379.1M | 268.58M | 271.05M | 147.36M | 84.11M | 64.35M | 59.66M | 88.87M | 19.02M |
| Short-Term Investments | 2.48B | 0 | 2.62B | 2.46B | 2.32B | 1.54B | 1.58B | 863M | 722M | 531M | 505M | 176M | 177M | 102.13M | 139.12M | 130.5M | 21.35M | 39.55M | 109.39M | 46.27M | 66.92M | 56.7M | 94.28M | 15.16M | 9.57M | 1.17M | 7.4M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11M | 13.74M | 0 | 0 | 0 | 0 | -92.53M | 0 | 0 | 0 | 0 | 23.1M | 2.85M | 2.52M | 2.58M |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.82B | 0 | 1.6B | 5.57B | 2.46B | 1.6B | 1.32B | 1.09B | 784M | 687M | 715M | 390M | 252M | 231M | 172.3M | 78.36M | 65.07M | 69.37M | 85.32M | 52.19M | 22.19M | 24.44M | 14.43M | 10.49M | 16.66M | 4.98M | 4.75M |
| Total Non-Current Assets | 36.19B | 41.67B | 44.45B | 43.88B | 46.74B | 49.88B | 45.33B | 20.67B | 18.9B | 13.15B | 11.83B | 3.73B | 2.8B | 1.73B | 1.37B | 1.25B | 1.29B | 1.09B | 784.81M | 672.78M | 443.16M | 395.43M | 303.64M | 252.39M | 117.24M | 29.32M | 19.3M |
| Property, Plant & Equipment | 2.09B | 2.35B | 2.43B | 2.42B | 4.99B | 6.96B | 2.77B | 2.78B | 1.71B | 1.1B | 797M | 518M | 445M | 395M | 375.89M | 349.62M | 326.34M | 230.42M | 175.86M | 135.88M | 110.69M | 67.2M | 0 | 23.11M | 6.29M | 3.8M | 1.36M |
| Fixed Asset Turnover | 90.80x | 82.74x | 67.22x | 63.77x | 28.99x | 18.11x | 40.06x | 26.83x | 35.24x | 43.82x | 50.95x | 43.94x | 37.21x | 27.50x | 21.58x | 14.91x | 13.63x | 17.81x | 19.13x | 20.38x | 20.59x | 22.41x | - | 33.31x | 73.31x | 86.03x | 162.76x |
| Goodwill | 10.84B | 10.84B | 17.56B | 17.56B | 18.81B | 19.77B | 18.65B | 6.86B | 7.01B | 4.75B | 4.71B | 842M | 751M | 348.43M | 256.29M | 281.98M | 278.05M | 224.59M | 163.38M | 141.03M | 135.88M | 157.28M | 101.63M | 13.07M | 0 | 0 | 0 |
| Intangible Assets | 4.36B | 4.53B | 5.41B | 6.1B | 6.91B | 7.82B | 8.39B | 2.06B | 2.24B | 1.4B | 1.54B | 155M | 123M | 48.78M | 20.27M | 27.43M | 29.11M | 22.48M | 17.57M | 13.21M | 16.2M | 17.37M | 14.44M | 6.29M | 10.7M | 2.4M | 15.54M |
| Long-Term Investments | 74.45B | 20.88B | 17.43B | 16.29B | 14.68B | 14.04B | 12.85B | 7.72B | 6.86B | 5.31B | 4.54B | 1.93B | 1.28B | 791.9M | 614.72M | 506.14M | 618.64M | 545.63M | 332.41M | 317.04M | 145.42M | 123.66M | 116.79M | 184.81M | 105M | 23.51M | 24.28M |
| Other Non-Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Assets | 81.17B | 77.66B | 82.44B | 84.64B | 76.87B | 78.38B | 68.72B | 40.99B | 30.9B | 21.86B | 20.2B | 7.34B | 5.84B | 3.53B | 2.74B | 2.19B | 1.94B | 1.7B | 1.45B | 1.12B | 894.98M | 668.03M | 527.93M | 362.69M | 210.33M | 131.37M | 66.02M |
| Asset Turnover | 2.42x | 2.51x | 1.98x | 1.82x | 1.88x | 1.61x | 1.62x | 1.82x | 1.95x | 2.21x | 2.01x | 3.10x | 2.84x | 3.08x | 2.96x | 2.38x | 2.29x | 2.41x | 2.32x | 2.47x | 2.55x | 2.25x | 1.90x | 2.12x | 2.19x | 2.49x | 3.35x |
| Asset Growth % | -8.95% | -5.8% | -2.59% | 10.11% | -1.92% | 14.05% | 67.63% | 32.66% | 41.39% | 8.21% | 175.2% | 25.71% | 65.42% | 28.73% | 25.17% | 12.68% | 14.19% | 17.31% | 29.67% | 25.04% | 33.97% | 26.54% | 45.56% | 72.44% | 60.11% | 98.99% | - |
| Total Current Liabilities | 40.05B | 21.48B | 34.26B | 36.72B | 28.46B | 25.77B | 21.59B | 12.93B | 11.97B | 9.33B | 8.62B | 3.63B | 2.9B | 1.56B | 1.2B | 837.61M | 765.25M | 715.91M | 640.98M | 486.8M | 387.95M | 214.65M | 202.16M | 128.79M | 101.93M | 67.28M | 51.97M |
| Accounts Payable | 16.83B | 20.54B | 13.02B | 16.25B | 9.35B | 8.29B | 7.07B | 4B | 4.05B | 4.17B | 3.76B | 976M | 768M | 338M | 219.07M | 216.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.71M | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 63M | 196M | 110M | 119M | 82M | 267M | 97M | 88M | 38M | 4M | 4M | 5M | 5M | 3M | 3.37M | 3.23M | 2.82M | 646K | 255K | 971K | 971K | 0 | 486K | 579K | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Liabilities | 5.37B | -50M | 18.31B | 18B | 16.75B | 14.24B | 12.23B | 7.47B | 6.83B | 4.29B | 3.93B | 2.3B | 1.72B | 1.14B | 972.28M | 607.99M | 645.09M | 20.68M | 31.01M | 25.5M | 33.82M | 14.35M | 3.96M | 3.67M | 10.75M | 58.56M | 51.97M |
| Current Ratio | 1.12x | 1.68x | 1.11x | 1.11x | 1.06x | 1.11x | 1.08x | 1.57x | 1.00x | 0.93x | 0.97x | 0.99x | 1.05x | 1.15x | 1.15x | 1.12x | 0.86x | 0.86x | 1.04x | 0.92x | 1.16x | 1.27x | 1.11x | 0.86x | 0.91x | 1.52x | 0.90x |
| Quick Ratio | 1.12x | 1.68x | 1.11x | 1.11x | 1.06x | 1.11x | 1.08x | 1.57x | 1.00x | 0.93x | 0.97x | 0.99x | 1.04x | 1.15x | 1.15x | 1.12x | 0.86x | 0.86x | 1.18x | 0.92x | 1.16x | 1.27x | 1.11x | 0.68x | 0.89x | 1.48x | 0.85x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 19.6B | 36.13B | 21.67B | 21.97B | 24.17B | 25.59B | 21.17B | 15.37B | 7.91B | 5.65B | 5.52B | 1.39B | 1.05B | 726.74M | 590.83M | 416.3M | 381.58M | 367.03M | 308.9M | 217.28M | 180.61M | 101.33M | 54.46M | 13.79M | 5.33M | 7.71M | 22.88M |
| Long-Term Debt | 16.31B | 17.97B | 18.42B | 17.71B | 17.94B | 18.57B | 16.68B | 13.64B | 6.65B | 4.7B | 4.65B | 1.22B | 888M | 665.7M | 535.48M | 348.34M | 327.82M | 307.08M | 264.64M | 206.41M | 174.65M | 92.45M | 46.97M | 7.62M | 0 | 0 | 4M |
| Capital Lease Obligations | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Deferred Tax Liabilities | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | 59.65B | 57.6B | 55.94B | 58.69B | 52.63B | 51.35B | 42.76B | 28.3B | 19.88B | 14.98B | 14.14B | 5.01B | 3.95B | 2.29B | 1.79B | 1.25B | 1.15B | 1.08B | 949.88M | 704.08M | 568.56M | 315.98M | 256.62M | 142.58M | 107.26M | 67.28M | 74.85M |
| Total Debt | 16.37B | 18.78B | 19.43B | 18.88B | 21.33B | 22.66B | 18.32B | 14.51B | 6.69B | 4.7B | 4.66B | 1.22B | 879M | 669M | 538.85M | 351.58M | 330.64M | 307.73M | 264.89M | 207.38M | 175.62M | 92.45M | 47.46M | 8.2M | 0 | 0 | 4M |
| Net Debt | -4.89B | 889M | 5.37B | 1.68B | 9.26B | 9.54B | 7.52B | 2.39B | 1.34B | 627M | 725M | -539M | -731M | -369M | -305.1M | -222.12M | -103.53M | -96.02M | -114.21M | -61.21M | -95.43M | -54.91M | -36.65M | -56.15M | -59.66M | -88.87M | -15.02M |
| Debt / Equity | 0.76x | 0.94x | 0.73x | 0.73x | 0.88x | 0.84x | 0.71x | 1.14x | 0.61x | 0.68x | 0.77x | 0.53x | 0.46x | 0.54x | 0.56x | 0.38x | 0.41x | 0.50x | 0.53x | 0.50x | 0.54x | 0.26x | 0.17x | 0.04x | - | - | - |
| Debt / EBITDA | -2.76x | - | 4.40x | 4.47x | 7.76x | 7.27x | 4.22x | 5.99x | 3.42x | 3.01x | 3.02x | 1.50x | 1.59x | 1.94x | 3.10x | 1.34x | 1.58x | 1.69x | 1.59x | 2.50x | - | 1.00x | 0.64x | 0.15x | - | - | 0.53x |
| Net Debt / EBITDA | 0.83x | - | 1.22x | 0.40x | 3.37x | 3.06x | 1.73x | 0.98x | 0.69x | 0.40x | 0.47x | -0.66x | -1.32x | -1.07x | -1.75x | -0.85x | -0.50x | -0.53x | -0.68x | -0.74x | - | -0.60x | -0.49x | -1.05x | -1.75x | -4.37x | -1.99x |
| Interest Coverage | -9.03x | -9.46x | 7.06x | 5.96x | 3.95x | 3.73x | 4.81x | 5.33x | 4.99x | 5.45x | 6.35x | 17.21x | 14.06x | 10.98x | 7.15x | 10.27x | 9.58x | 9.43x | 9.19x | 5.10x | -1.04x | 22.52x | 104.36x | 268.49x | 915.13x | - | - |
| Total Equity | 21.5B | 20.06B | 26.51B | 25.96B | 24.24B | 27.02B | 25.96B | 12.69B | 11.02B | 6.88B | 6.05B | 2.32B | 1.89B | 1.24B | 953.77M | 936.42M | 797.05M | 619.43M | 501.27M | 415.05M | 326.42M | 352.05M | 271.31M | 220.12M | 102.18M | 64.09M | -8.83M |
| Equity Growth % | -70.62% | -24.35% | 2.13% | 7.09% | -10.31% | 4.08% | 104.55% | 15.14% | 60.31% | 13.58% | 160.5% | 22.9% | 52.13% | 30.33% | 1.85% | 17.48% | 28.68% | 23.57% | 20.77% | 27.15% | -7.28% | 29.76% | 23.26% | 115.41% | 59.44% | 825.48% | - |
| Book Value per Share | 43.39 | 40.84 | 50.62 | 47.56 | 41.64 | 45.76 | 44.83 | 30.19 | 27.66 | 19.47 | 18.46 | 9.44 | 7.86 | 5.52 | 4.44 | 4.46 | 3.95 | 3.49 | 2.82 | 2.31 | 1.89 | 1.95 | 1.56 | 1.43 | 0.73 | 0.67 | -0.11 |
| Total Shareholders' Equity | 21.43B | 19.95B | 26.41B | 25.84B | 24.06B | 26.8B | 25.77B | 12.55B | 10.92B | 6.85B | 5.89B | 2.16B | 1.74B | 1.23B | 953.06M | 935.63M | 793.94M | 600.85M | 501.27M | 415.05M | 326.42M | 352.05M | 271.31M | 220.12M | 102.18M | 64.09M | -8.83M |
| Common Stock | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 0 | 0 | 4.35B | 0 | 0 | 0 | 59K | 55K | 54K | 52K | 46K | 43K | 44K | 44K | 43K | 41K | 20K | 11K | 10K | 0 |
| Retained Earnings | 10.21B | 8.67B | 15.35B | 12.04B | 9.34B | 8.14B | 6.79B | 4.98B | 3.66B | 2.75B | 1.92B | 1.36B | 1B | 731.92M | 566.82M | 564.96M | 453.74M | 358.91M | 275.24M | 191.74M | 118.29M | 161.92M | 106.29M | 61.98M | 28.71M | 3.09M | -9.29M |
| Treasury Stock | -9.44B | -9.44B | -9B | -5.86B | -4.21B | -1.09B | -816M | -214M | -139M | -244M | -179M | -147M | -98M | -89M | -69.86M | -57.12M | -50.49M | -47.26M | -41M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -171M | -58M | -504M | -652M | -1.13B | 77M | 337M | 134M | -56M | -3M | -36M | -10M | -1M | -2.62M | 5.19M | 5.76M | 6.42M | 7.35M | 3.15M | 0 | -1.25M | -1.75M | 0 | 740K | 1.09M | 135K | 81K |
| Minority Interest | 75M | 103M | 100M | 116M | 180M | 227M | 189M | 141M | 106M | 26M | 159M | 167M | 147M | 9M | 711K | 785K | 3.12M | 18.58M | 0 | 0 | 0 | 0 | 0 | 0 | 881K | 0 | 0 |
Regulatory and medical trend volatility
As reported in recent financial statements, Centene's total assets reached $81.2 billion in 2026Q1, reflecting a stabilization of the balance sheet after the significant asset volatility and divestiture-related fluctuations observed throughout the 2025 fiscal year as the company executed its Value Creation Plan.
The recent stabilization in total assets suggests that the company's strategic narrowing of its portfolio is beginning to yield a more predictable capital base. Investors should monitor whether this trend persists, as the reduction in asset volatility is a necessary precursor to restoring consistent long-term shareholder value.
According to the latest quarterly filings, Centene's debt-to-equity ratio improved to 0.76 in 2026Q1, down from the 0.94 peak observed in 2025Q4, indicating a concerted effort by management to deleverage the balance sheet while navigating ongoing operational restructuring and market-wide medical cost pressures.
The reduction in leverage appears to be a deliberate move to improve financial flexibility in a high-interest-rate environment. While the current debt levels remain manageable, the company's reliance on government-sponsored revenue streams necessitates a conservative approach to debt to ensure resilience against potential state-level contract re-procurement risks.
Based on the provided balance sheet data, Centene's cash and equivalents surged to $21.3 billion in 2026Q1, representing a significant liquidity buffer that provides the company with substantial protection against the inherent volatility of government-sponsored healthcare payment cycles and potential medical loss ratio spikes.
This robust cash position suggests that the company is prioritizing liquidity to navigate the uncertainty of Medicaid redeterminations and potential regulatory shifts. Such a large cash pile may also provide the optionality needed to pursue strategic investments or further debt reduction if market conditions deteriorate.
As indicated by the reported figures, Centene's equity base experienced significant fluctuations, dropping from $27.9 billion in 2025Q1 to $21.4 billion in 2026Q1, largely driven by the accounting impact of divestitures and restructuring charges associated with the company's ongoing Value Creation Plan.
The contraction in equity highlights the tangible cost of the company's strategic pivot away from non-core assets. While these actions may improve long-term operational focus, the resulting impact on book value warrants careful investigation into whether the remaining asset base can generate sufficient returns on equity to satisfy investor expectations.
Based on historical balance sheet data, Centene's goodwill and intangible assets, which stood at $10.8 billion in 2026Q1, represent a significant portion of the company's equity, posing a potential risk of future impairment charges if the acquired businesses fail to meet long-term performance targets.
The reduction in goodwill from $17.6 billion in 2025Q2 suggests that recent divestitures have successfully purged some of the acquisition-related bloat. However, the remaining balance remains a critical area for investors to monitor, as any further deterioration in the performance of core segments could necessitate additional write-downs.
Quick answers to the most common questions about buying CNC stock.
As of 2025, Centene Corporation (CNC) had total assets of $77.66B including $35.99B in current assets.
Centene Corporation (CNC) carries total debt of $18.78B, offset by $17.89B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Centene Corporation (CNC) has total shareholders' equity (book value) of $19.95B ($40.84 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Centene Corporation (CNC) reported a current ratio of 1.68x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.